Skip to main content
Livermore
Livermore
ZHEN

Halozyme Therapeutics, Inc.

HALO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001159036

In the last 90 days, Halozyme Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 674 institutions reported holding it in 13F filings for Q2 2026, worth $9.62B in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Halozyme Therapeutics, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of HALO: Q1 2024 compared with Q2 2024
MeasureQ1 2024Of which not filed for Q2 2024Q2 2024Change
Holders4132460+49
Shares123.7M212.2K122.3M−1.22M (−1.0%)
Value$5.03B$8.75M$6.40B+$1.38B (+27.4%)

2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (79)

Institutions that held Halozyme Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to HALO in Q2 2024
InstitutionSharesValue% of portfolio
Boston Trust Walden Corp443,295$23.2M0.17%
Corebridge Financial, Inc.227,122$11.9M0.07%
Lombard Odier Asset Management (Europe) Ltd200,000$10.5M0.51%
Nicholas Investment Partners, LP152,869$8.00M0.83%
Castellan Group, LLC108,922$5.70M2.72%
Clark Capital Management Group, Inc.102,925$5.39M0.04%
Chase Investment Counsel Corp91,337$4.78M1.70%
Mirae Asset Global ETFs Holdings Ltd.76,580$4.01M0.01%
Readystate Asset Management LP57,970$3.04M0.14%
Calamos Advisors LLC43,968$2.30M0.01%
Connor, Clark & Lunn Investment Management Ltd.37,082$1.94M0.01%
Redhawk Wealth Advisors, Inc.35,613$1.86M0.29%
Bayesian Capital Management, LP31,260$1.64M0.19%
Marietta Investment Partners LLC28,242$1.48M0.32%
Altshuler Shaham Ltd27,000$1.41M0.05%
Schonfeld Strategic Advisors LLC26,394$1.38M0.01%
Convergence Investment Partners, LLC26,246$1.37M0.40%
Alberta Investment Management Corp25,800$1.35M0.01%
Caxton Associates LP25,432$1.33M0.05%
Entropy Technologies, LP24,969$1.31M0.14%
Intech Investment Management LLC22,763$1.19M0.01%
James Investment Research Inc21,172$1.11M0.13%
Brevan Howard Capital Management LP19,808$1.04M0.07%
Chiron Investment Management, LLC19,011$995.4K0.39%
Sanctuary Advisors, LLC20,528$791.8K0.01%
Atria Investments LLC14,981$784.4K0.01%
Legato Capital Management LLC14,613$765.1K0.10%
Algert Global LLC12,791$669.7K0.02%
RSM US Wealth Management LLC12,736$662.6K0.01%
Atria Wealth Solutions, Inc.11,552$604.9K0.01%
Oak Hill Wealth Advisors, LLC10,800$565.5K0.17%
Paloma Partners Management Co9,900$518.4K0.04%
Alhambra Investment Partners LLC9,190$481.2K0.26%
HRT Financial LP9,155$479.0K0.00%
Centiva Capital, LP8,884$465.2K0.02%
Wolff Wiese Magana LLC8,591$449.8K0.36%
Argent Capital Management LLC8,346$437.0K0.01%
Curbstone Financial Management Corp8,240$431.4K0.09%
Diversify Wealth Management, LLC7,331$382.0K0.05%
Sheets Smith Wealth Management6,848$358.6K0.04%
Procyon Private Wealth Partners, LLC6,266$328.1K0.02%
Omers Administration Corp6,200$324.6K0.00%
Mitsubishi UFJ Trust & Banking Corp6,050$316.8K0.00%
Vinva Investment Management Ltd4,066$315.2K0.02%
Kestra Advisory Services, LLC4,961$259.8K0.00%
Laurion Capital Management LP4,791$250.9K0.01%
O'Neil Global Advisors, Inc.4,750$249.0K0.12%
Raymond James Trust N.A.4,689$245.5K0.01%
Miracle Mile Advisors, LLC4,345$227.5K0.01%
Fifth Third Wealth Advisors LLC4,296$224.9K0.02%
Capstone Investment Advisors, LLC4,230$221.5K0.00%
Evercore Wealth Management, LLC4,143$216.9K0.00%
Susquehanna Fundamental Investments, LLC4,000$209.4K0.00%
Hoylecohen, LLC4,000$209.4K0.02%
Mercer Global Advisors Inc3,484$208.9K0.00%
Portside Wealth Group, LLC3,931$205.8K0.04%
Belpointe Asset Management LLC3,877$203.0K0.01%
United Capital Financial Advisers, LLC3,858$202.0K0.00%
Ashton Thomas Private Wealth, LLC3,720$194.8K0.01%
Penserra Capital Management LLC2,625$137.0K0.00%
Skandinaviska Enskilda Banken AB (publ)927$48.5K0.00%
International Assets Investment Management, LLC639$33.5K0.00%
Jones Financial Companies LLLP381$19.9K0.00%
Blair William & Co312$16.3K0.00%
Richardson Financial Services Inc.260$13.6K0.01%
Bokf, NA92$4.82K0.00%
Triad Wealth Partners, LLC85$4.45K0.00%
Stephens Consulting, LLC68$3.56K0.00%
Innealta Capital, LLC68$3.56K0.00%
Cohen & Steers, Inc.48$2.00K0.00%
HighMark Wealth Management LLC30$1.57K0.00%
Financial Network Wealth Advisors LLC28$1.47K0.00%
Johnson Financial Group, Inc.22$1.15K0.00%
TD Private Client Wealth LLC22$1.15K0.00%
Benjamin F. Edwards & Company, Inc.23$1.00K0.00%
Capital Advisors, Ltd. LLC12$1.00K0.00%
Ronald Blue Trust, Inc.11$4470.00%
Harbor Investment Advisory, LLC4$2090.00%
MV Capital Management, Inc.1$530.00%

Sold out (30)

Institutions that held Halozyme Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of HALO in Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Cubist Systematic Strategies, LLC319,296$13.0M
Cutter Capital Management, LP255,049$10.4M
American International Group, Inc.237,773$9.67M
Lombard Odier Asset Management (Switzerland) SA175,000$7.12M
Winton Group Ltd148,130$6.03M
AXA S.A.135,203$5.50M
Texas Permanent School Fund114,745$4.67M
Marshall Wace, LLP75,533$3.07M
Capital Fund Management S.A.59,552$2.42M
Wafra Inc.53,877$2.19M
Duality Advisers, LP26,094$1.06M
Y-Intercept (Hong Kong) Ltd24,900$1.01M
Aigen Investment Management, LP24,033$977.7K
Dynamic Technology Lab Private Ltd19,129$778.0K
Arbor Investment Advisors, LLC17,950$730.2K
Gsa Capital Partners LLP11,217$456.0K
Deerfield Management Company, L.P. (Series C)11,042$449.2K
United Services Automobile Association10,057$409.1K
Coastal Bridge Advisors, LLC10,000$406.8K
Infrastructure Capital Advisors, LLC8,147$331.4K
Point72 (DIFC) Ltd8,045$327.3K
Metropolitan Life Insurance Co6,821$277.5K
Point72 Asia (Singapore) Pte. Ltd.6,590$268.1K
Teza Capital Management LLC5,996$243.9K
Old National Bancorp5,207$211.8K
Elequin Capital LP374$15.2K
VitalStone Financial, LLC67$3.00K
SYSTM Wealth Solutions LLC71$2.89K
Nelson, Van Denburg & Campbell Wealth Management Group, LLC26$1.06K
Newbridge Financial Services Group, Inc.10$407

Not filed for Q2 2024 yet (2)

Institutions that held Halozyme Therapeutics, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding HALO in Q1 2024 that haven't filed for Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Credit Suisse AG201,642$8.20M
Shell Asset Management Co10,535$552.0K